Results for tag: "Enteric Softgel Capsules"

In the realm of drug delivery, Enteric Softgel Capsules represent a specialized form of oral dosage designed to bypass the acidic environment of the stomach and release their active ingredients in the more neutral pH of the small intestine. This technology provides a targeted delivery system that can enhance the bioavailability of certain medications, protect acid-sensitive compounds, and mitigate stomach irritation. Enteric Softgel Capsules are particularly beneficial for drugs that are intended to act locally in the intestines or require absorption in the intestinal region for systemic effects. The market for these capsules encompasses a range of pharmaceutical applications, from over-the-counter dietary supplements to prescription medications aimed at treating specific conditions. Their development is driven by the need for precision in drug release profiles and improved patient compliance due to the reduced gastric discomfort associated with certain medications. Companies operating in the Enteric Softgel Capsules market focus on pharmaceutical manufacturing, drug formulation, and advanced delivery technologies. Some prominent players include Catalent Inc., which specializes in delivery technologies and development solutions; Aenova Group, providing end-to-end development and manufacturing services; Sirio Pharma, a contract manufacturer with expertise in softgel technologies; and Capsugel, now a Lonza company, known for its wide array of capsule delivery solutions for the healthcare industry. Other companies involved in this market offer various services that range from custom formulation to contract manufacturing, working in collaboration with pharmaceutical companies to develop and supply enteric softgel capsules tailored to specific therapeutic needs. Show Less Read more